Tag: STRIDE trial
Cerevasc completes enrolment in STRIDE pivotal trial of eShunt system
Cerevasc has announced it has completed patient enrolment in its STRIDE pivotal trial evaluating the investigational eShunt system in patients with normal-pressure hydrocephalus (NPH).
With...
Cerevasc announces 100th patient treated with eShunt system
Cerevasc has announced that the 100th patient has received treatment for communicating hydrocephalus with the company’s eShunt system. These 100 patients have been enrolled...
